Daivobet

Daivobet

betamethasone + calcipotriol

Manufacturer:

LEO Pharma

Distributor:

DKSH
Concise Prescribing Info
Contents
Per g Calcipotriol hydrate 50 mcg, betamethasone dipropionate 0.5 mg
Indications/Uses
Initial topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy.
Dosage/Direction for Use
Apply once daily to affected area. Recommended treatment period: 4 wk. Max: Not to exceed 15 g daily. Max treated area: Not to exceed 30% BSA.
Contraindications
Hypersensitivity. Ca metabolism disorders, viral, fungal or bacterial skin infections, parasitic infections, skin TB manifestations, rosacea, perioral dermatitis, acne vulgaris, skin atrophy, striae atrophicae, fragility of skin veins, ichthyosis, acne rosacea, ulcers & wounds; erythrodermic, exfoliative & pustular psoriasis.
Special Precautions
Discontinue use if infection worsens or hypercalcaemia occurs. Risk of generalised pustular psoriasis or rebound effects upon discontinuation; guttate psoriasis. Avoid application under occlusive dressings, on large areas of damaged skin, on mucous membranes or in skin folds. Avoid contact w/ face, mouth & eyes. Limit or avoid excessive exposure to either natural or artificial sunlight. Avoid concurrent treatment w/ other steroids. Long-term use. Severe renal insufficiency or hepatic disorders. Pregnancy & lactation.
Adverse Reactions
ATC Classification
D05AX52 - calcipotriol, combinations ; Belongs to the class of other antipsoriatics for topical use.
Presentation/Packing
Form
Daivobet oint
Packing/Price
30 g x 1's (RM134.3/tube)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in